Similar articles

• Letter: Metiamide in Zollinger-Ellison syndrome.

  Thompson MH, Vanables CW, Miller IT, Reed JD, Sanders DJ, Grund ER, Blair EL. Thompson MH, et al. Lancet. 1975 Jan 4;1(7897):35-6. doi: 10.1016/s0140-6736(75)92392-2. Lancet. 1975. PMID: 46947 No abstract available.
• Letter: Metiamide in Zollinger-Ellison syndrome.

  Sullivan SN. Sullivan SN. Lancet. 1975 Mar 1;1(7905):516. doi: 10.1016/s0140-6736(75)92853-6. Lancet. 1975. PMID: 46977 No abstract available.
• [Letter: Treatment of Zollinger-Ellison syndromes with metiamide or cimetidine. Potential risk of hyperimmunization manifestations].

  Moulias R, Congy F. Moulias R, et al. Nouv Presse Med. 1976 Jan 17;5(3):149-50. Nouv Presse Med. 1976. PMID: 4772 French. No abstract available.
• The use and abuse of histamine H2-receptor antagonists.

  Milton-Thompson GJ. Milton-Thompson GJ. J R Nav Med Serv. 1977 Spring;63(1):9-14. J R Nav Med Serv. 1977. PMID: 17005 Review. No abstract available.
• H2 receptor antagonists.

  Siepler JK, Campagna KD, Donahue PE, Bombeck CT. Siepler JK, et al. Am J Hosp Pharm. 1978 Feb;35(2):141-5. Am J Hosp Pharm. 1978. PMID: 24338 Review.